On 29 march 2025, a seminar on “respiratory infectious diseases prevention and control strategies and vaccine applications”, organized by the zhejiang preventive medicine association and hosted by the chinese association of preventive medicine, was held in hangzhou. The seminar was an academic conference focusing on the prevention and control of respiratory infections, aimed at raising the level of public health services and raising public awareness of the prevention of respiratory infections. The conference brought together a large number of leading national and international experts and practitioners in the field of disease prevention and control to discuss strategies for the prevention and control of respiratory infectious diseases and vaccine applications。
Site of the seminar on respiratory infectious diseases strategy and vaccine applications
During the meeting, several experts conducted in-depth analyses of key points of respiratory infections and their immunization. Experts noted that the wide variety of respiratory infections, their rapid spread and the wide range of people targeted posed a serious threat to the health of the population. Pneumonia from the current, measles to whooping cough, not only affects the quality of life of patients, but can also cause many complications and increase the medical burden. Immunization prevention is a powerful weapon for the control of respiratory infections, which can effectively stimulate human immune responses through vaccinations, create immune barriers, disrupt the transmission of pathogens and prepare for protection in advance. Experts stressed that scientific planning for immunization, rational choice of vaccine types and procedures for vaccination were essential for building group immunization。
Experts from the centers for disease prevention and control in zhejiang province provided in-depth information on the development and application of vaccines for respiratory infections. From traditional to new types of multi-priced vaccines, as technology continues to improve, there are more options for preventing respiratory infections. She mentioned that the 13-price pneumococcal vaccine covered the main serotypes that gave rise to pneumococcal infections and provided broader and more reliable protection for children。
Experts from the shanghai city centers for disease prevention and control demonstrated the effectiveness of the 13-valent pneumococcal vaccine in its practical application through extensive data and case analysis. Safety observations are good after the introduction of the 13-priced pneumococcal pneumococcal combined vaccine (tt carrier) and the incidence of adverse effects is low. Better protection can be achieved with the high incidence of pneumococcal diseases in infants and young children being vaccinated at the earliest possible opportunity, with clear economic benefits in considering the inclusion of 13-priced pneumococcal vaccines in immunization planning. These findings provide a strong basis for vaccine coverage and give participants confidence in the quality and effectiveness of nationally produced vaccines。
Pneumococcal diseases are characterized by high rates of morbidity, drug resistance and high incidence of after-effects, and children under five years of age are a vulnerable group, which is classified by the world health organization as a disease requiring extremely high priority for vaccine prevention. Inoculation against pneumocococcal disease at 13 per cent is one of the most cost-effective prevention and control measures. To date, 13 per cent of the national production of pneumocococcal pneumococcus, combined with sugar, has been approved。
The successful organization of the meeting had not only created a platform for exchange between expert scholars and front-line staff, but had also facilitated academic exchanges and practical innovations in the field of control of respiratory infectious diseases. The 13-priced pneumococcal vaccine, as a powerful weapon to protect children, has helped to reduce the incidence and mortality of pneumocococcal diseases among infants aged 5 and under and to keep more children from the threat of pneumocococcal diseases. Looking ahead, as vaccine research and development technologies continue to advance, prevention and control strategies continue to optimize, and public health awareness progresses, efforts to prevent and control respiratory infectious diseases will lead to greater breakthroughs in establishing solid lines of defence to safeguard people's health and build healthy china。
